Steve joined KAI as President and CEO in October 2004.  He has over twenty years of pharmaceutical, biotechnology and start-up experience in the life science industry.  Steve began his career in new product planning at Eli Lilly followed by California Biotechnology (Scios/J&J).  In 1990 he joined Landec Corporation, a specialty materials company, as Vice President of Business Development and General Manager.  During his 7 years at Landec Steve led commercial strategy, product launches and negotiated multiple diverse alliances leading to an IPO in 1995.  Steve then became Vice President of Business Development at Isis, where he was instrumental in establishing business units in functional genomics and small molecule discovery and negotiating partnerships with Merck, Zeneca, and Abbott.  In 1999 Steve joined Sunesis as Senior Vice President and member of the board of directors, and later, Chief Business Officer.  At Sunesis he played a key role in raising over $80 million of venture and partner financing and securing alliances with Merck, J&J, and Biogen.  Most recently, Steve was Senior Vice President of Commercial Operations at Exelixis.  Steve has a biology degree from Brown University and a Masters in Management from the Kellogg School of Northwestern University.